ALFA FinderBSE filing, NSE: INDOCO. Summary written from the filing by ALFA Finder's alert engine.
Indoco Remedies Ltd: key numbers
- Share price
- ₹215.06
- Market cap
- ₹1,985 Cr
- Revenue (annual)
- ₹1,845 Cr
- Net profit (annual)
- ₹-95.14 Cr
- P/E (TTM)
- 62.2×Sector 43.0×
- Promoter holding
- 58.92%+0.06% QoQ
- FII holding
- 1.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indoco Remedies Ltd
All →Indoco Remedies Promoter Buying: ₹0.45 Cr
Four Indoco Remedies promoters bought 20,740 shares on NSE on 5 November 2026. Aggregate purchase value is about Rs.0.45 Crore.
- Value
- ₹0.45 Cr
Indoco Remedies Promoter Buying: ₹0.03 Cr
Indoco Remedies promoter and director Suresh G Kare bought 1,335 equity shares on the open market on 6 November 2026, raising holding from 1.42% to 1.42%. The trade value is Rs.2,84,248, about Rs.0.03 Crore.
- Value
- ₹0.03 Cr
Indoco Remedies Promoter Buying: ₹0.13 Cr
Indoco Remedies promoters Aditi M. Panandikar and Madhura Suresh Kare acquired a combined 5,996 equity shares via market purchase. The total transaction value is ₹0.13 Crore.
- Value
- ₹0.13 Cr
- Promoter stake change
- +0.01%
Indoco Remedies Promoter Buying: ₹0.17 Cr
Indoco Remedies' promoters Aditi Panandikar and Madhura Suresh Kare acquired 8,004 shares via market purchase. The total transaction value is ₹0.17 Crore.
- Value
- ₹0.17 Cr
Indoco Remedies Earnings Call Transcript: Key Takeaways
Indoco Remedies hit record quarterly revenue exceeding ₹500 Cr, but faced margin compression from elevated geopolitical freight and material costs.
- Call
- Guides 10% growth
Indoco Remedies Business Update
Indoco's CRO AnaCipher received ANVISA Brazil approval for clinical and bioanalytical facilities. This expands its regulatory footprint to conduct bioequivalence studies in Brazil and Latin America.
Other annual general meeting announcements
All →Generic Engineering Construction and Projects Annual General Meeting
Generic Engineering's 32nd AGM is scheduled for November 30, 2026 via VC/OAVM. Agenda includes FY26 financial statements, director reappointment and related-party transactions approval.
Kirloskar Industries Annual General Meeting
Kirloskar Industries forwarded its subsidiary KFIL's postal ballot scrutinizer report. Shareholders passed resolutions appointing Ajay Shriram Patil as a director and as Joint Managing Director.
Umiya Tubes Annual General Meeting
Umiya Tubes submitted voting results and the scrutinizer report for its postal ballot ending 7 November 2026. Resolution 1, alteration of the name clause, passed as a special resolution with 100% of votes cast in favour.
Prime Focus Annual General Meeting
Prime Focus Limited's EOGM held on 7 November 2026 passed all resolutions with requisite majority. Resolutions cover cessation of control over Brahma AI Holdings and related party transactions involving its subsidiaries.
Jagsonpal Services Annual General Meeting
Jagsonpal Services shareholders approved an asset-acquisition business transfer agreement with Elanistech via postal ballot. A name-change certificate was also noted.
Vineet Laboratories Annual General Meeting
Vineet Laboratories has circulated notice of its 10th AGM, scheduled for 30 November 2026 via video conferencing. The filing attaches the FY 2025-26 annual report.